Antonio Dávalos Selected Research

Hyperglycemia

10/2010	Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome.
3/2003	Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Dávalos Research Topics

Disease

15	Stroke (Strokes) 01/2022 - 05/2002
13	Ischemic Stroke 01/2022 - 08/2002
5	Infarction (Infarctions) 02/2009 - 03/2003
3	Brain Ischemia (Cerebral Ischemia) 01/2022 - 04/2008
3	Brain Edema (Cerebral Edema) 07/2008 - 09/2005
3	Hypertension (High Blood Pressure) 01/2006 - 05/2002
3	Lacunar Stroke 01/2006 - 05/2002
2	Hyperglycemia 10/2010 - 03/2003
2	Brain Injuries (Brain Injury) 07/2008 - 03/2003
2	Inflammation (Inflammations) 01/2006 - 10/2005
2	Cerebral Infarction 12/2003 - 03/2003
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2013
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2012
1	Edema (Dropsy) 01/2007
1	Hematoma 01/2007
1	Iron Overload 01/2007
1	Headache (Headaches) 10/2005
1	Hypothermia 09/2005
1	Ischemia 12/2003
1	Disease Progression 03/2003
1	Hyperthermia 03/2003
1	Hyperlipidemias (Hyperlipidemia) 05/2002

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 06/2013 - 10/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2006 - 05/2002
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2007
2	Interleukin-10 (Interleukin 10)IBA 06/2013 - 03/2003
2	Glucose (Dextrose)FDA LinkGeneric 02/2009 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005 - 12/2003
2	InterleukinsIBA 12/2003 - 03/2003
2	CytokinesIBA 03/2003 - 05/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Anabolic Androgenic SteroidsIBA 03/2013
1	Insulin (Novolin)FDA Link 10/2010
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2009
1	Proteins (Proteins, Gene)FDA Link 08/2009
1	HaptoglobinsIBA 08/2009
1	Atrial Natriuretic Factor (ANF)IBA 01/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2009
1	Endothelin-1 (Endothelin 1)IBA 07/2008
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 07/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008
1	N-Methylaspartate (NMDA)IBA 04/2008
1	Glutamic Acid (Glutamate)FDA Link 04/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2008
1	erucylphosphocholineIBA 10/2007
1	Ferritins (Ferritin)IBA 01/2007
1	IronIBA 01/2007
1	Neuroprotective AgentsIBA 06/2005
1	9-deoxy-delta-9-prostaglandin D2IBA 06/2005
1	ProstaglandinsIBA 06/2005
1	Interleukin-4 (Interleukin 4)IBA 03/2003
1	Heparin (Liquaemin)FDA LinkGeneric 08/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2002

Therapy/Procedure

6	Therapeutics 01/2019 - 09/2005
3	Thrombectomy 01/2022 - 01/2014
2	Thrombolytic Therapy 01/2019 - 01/2007
1	Embolectomy 01/2021
1	Contraindications 01/2014
1	Secondary Prevention 10/2012
1	Aftercare (After-Treatment) 01/2007